Breast cancer patients with a positive Bcl-2 protein expression are considered to have a better prognosis [75], and Bcl-2 is significantly associated with several favorable prognostic factors such as tumor size, ER and progesterone receptor positivity [73, 76]. Here, ESR1 is linked to neoplasm.